Inactive Instrument
Aradigm Corporation Stock OTC Bulletin Board
Stocks
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.89M 4.28M 3.95M 3.64M 6.88M 471M 6.98M 47.24M 18.53M 230M 18.34M 17.94M 794M | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.8M 11.22M 10.36M 9.54M 18.02M 1.23B 18.3M 124M 48.53M 604M 48.06M 47.01M 2.08B | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 702K | |
| -0.49% | -3.58% | -0.84% | +2.13% | 49.18B | |
| -3.10% | -3.47% | +370.99% | +567.62% | 39.58B | |
| -0.46% | +3.98% | +5.44% | +60.79% | 34.69B | |
| -1.14% | -1.90% | +26.94% | -9.56% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.54% | -6.91% | - | - | 16.21B | |
| -1.82% | -1.91% | +69.28% | +112.51% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.25% | -0.92% | +15.77% | -32.78% | 13.02B | |
| Average | -1.35% | -0.17% | +63.00% | +93.69% | 27.07B | |
| Weighted average by Cap. | -1.43% | -0.38% | +75.91% | +117.65% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 195K 171K 158K 145K 275K 18.8M 279K 1.89M 739K 9.2M 732K 716K 31.68M | 14.46M 12.68M 11.7M 10.78M 20.36M 1.39B 20.68M 140M 54.85M 682M 54.31M 53.13M 2.35B |
| Net income | -32.94M -28.87M -26.65M -24.54M -46.37M -3.18B -47.09M -319M -125M -1.55B -124M -121M -5.35B | -10.7M -9.38M -8.66M -7.98M -15.07M -1.03B -15.31M -104M -40.59M -505M -40.2M -39.32M -1.74B |
| Net Debt | -9.37M -8.21M -7.58M -6.98M -13.19M -904M -13.4M -90.63M -35.54M -442M -35.19M -34.42M -1.52B | 7.91M 6.94M 6.4M 5.9M 11.14M 763M 11.31M 76.52M 30.01M 373M 29.71M 29.06M 1.29B |
Employees
-
